Dr Daren E Carling, MD | |
301 W Pine St, Blacksburg, SC 29702-1549 | |
(864) 839-4325 | |
(864) 839-9901 |
Full Name | Dr Daren E Carling |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 301 W Pine St, Blacksburg, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164495594 | NPI | - | NPPES |
235034 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 23503 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Daren E Carling, MD 301 W Pine St, Blacksburg, SC 29702-1549 Ph: (864) 839-4325 | Dr Daren E Carling, MD 301 W Pine St, Blacksburg, SC 29702-1549 Ph: (864) 839-4325 |
News Archive
The results of a randomized controlled trial presented today at the Annual European Congress of Rheumatology demonstrate high levels of treatment success in approximately two thirds of patients despite tapered glucocorticoid discontinuation, while a small loss of disease control was observed at the total study population level.
The WT Grant Foundation and the Spencer Foundation have jointly awarded the Urban Food Policy Institute at the CUNY Graduate School of Public Health and Health Policy a grant to study successful strategies for expanding enrollment, benefits, access, and impact of food benefit programs such as SNAP, WIC, and School Meals in response to the COVID-19 pandemic.
House Budget Chairman Paul Ryan was unbowed Thursday after the expected, but nonetheless stinging, rejection of his budget and Medicare proposal by the Senate. Ryan told NPR reporters he would do it all over again.
There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.
› Verified 3 days ago